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(1) 
PREFACE 
 
Bronchial  asthma  and  rhinosinusitis   are common  respiratory  diseases  that often 
coexist . Furthermore and of considerable interest is the possiblity that severity of asthma 
is  influenced by the upper airway diseases. The influence and interaction  between 
asthma and rhinitis exist with chronic rhinosinusitis, allergic rhinitis and viral respiratory 
tract infection. These observations raise the possiblity that events in the upper respiratory 
tract can influence lower respiratory tract. The first suggestion of possible association of  
upper and lower respiratory tract pathology  comes from the studies demonstrating  that 
asthmatics have abnormal paranasal sinus radiographs(1).         
                             
The next logical step performed was to see if aggressive treatment of paranasal sinus  
diseases could improve asthma . Many symptoms and signs are shared between upper and 
lower   respiratory  tracts and its important that these symptoms  should consider 
differential  diagnosis of both systems . Although historically it was believed that 
structurally  and functionally  there are differences within the respiratory tract  which is 
used to divide it in to the upper and lower respiratory tracts . Its now being appreciated  
the concept of one airway and one disease. Despite many studies supporting an 
association between rhinosinusitis and bronchial hyper responsiveness, controversy still 
remains whether treating one airway disease can ameliorate another?(7). 
 
  
(2) 
 
 
AIM 
 
 
To  study  the  impact of   the   management  of  Chronic rhinosinusitis  in  the clinical   
course   of  Bronchial asthma  in  terms  of  patients symptoms subjectively & Peak  
expiratory  flow  rate objectively. 
 
 
 
 
 
 
 
 
 
 
 
 
  
(3) 
HISTORY 
 
During  2nd  Century A.D.,Galen   observed   relationship    between    nasal   infection  
and   wheezing. 
 
In   1919 ,  Sluder  hypothesised   Sinopulmonary   reflex. (12). 
 
In   1928,  French   physiologist   Kratchmer   observed   stimulation  of  nasal   mucosa 
and   bronchial    hyperresponsiveness. 
 
In   1969,  Kaufman     and    Wright   found   silica   particles   applied   to   nasal mucosa 
increase lower airway resistance(3). 
 
 
                    
 
 
 
 
 
  
(4) 
ANATOMY OF THE AIRWAY 
 
EMBRYOLOGY OF NOSE AND NASAL CAVITY: 
 
At about 4 weeks of intrauterine life bilateral ectodermal thickenings appear in the 
frontonasal process above the stomatodeum called as nasal placode (or) olfactory 
placodes. 
 
The nasal  placodes invaginates to form the olfactory (or) nasal pit & it is continous 
with the stomatodeum below. Proliferating mesoderm around the pit raises above the 
surface medially & laterally to from the medial & lateral nasal process respectively . 
 
The nasal pits deepens to form nasal sac by 5 wks.Nasal sacs expand dorsally &                   
caudally,separated from stomatodeum by bucconasal membrane or oronasal   
membrane with progressive  thinning of mesoderm dorsally & caudally  . The  
maxillary process of the 1st arch fuse with medial nasal fold & frontonasal fold which 
closes the nasal pit in to widely separated primitive nasal cavities. 
 
The bucconasal membrane separating primitive nasal cavity & stomatodeum breaks at 
14-15mm stage. Primitive posterior nasal aperture is in horizontal plane. 
  
(5) 
The  maxillary process fuses with lateral nasal fold forming the nasomaxillary        
groove which  later canalises to form nasolacrimal duct. 
 
Lateral  nasal  fold   forms  nasal  bone, upper  lateral  cartilage  &   lower lateral 
cartilage. 
 
Medial   nasal  fold   forms  Premaxilla ,  upper lip   &   medial   crus  of  lower  
lateral cartilage. 
 
Mesoderm of the lateral part of the upperlip is derived from maxillaryprocessand 
philtrum from the frontonasal process.  
 
Primitive palate begins to form anteriorly by fusion of maxillary &frontonasal 
processes. 
 
A midline ridge develops from the posterior edge of the frontonasal process in the 
roof of stomatodeum to the rathke’s pouch which forms nasal septum. 
 
As  the nasal cavity enlarges the palatal process of maxillary mesoderm grows 
medially towards each other & the septum. Fusion occur from anterior to posterior. 
 
  
(6) 
 
DEVELOPMENT OF TURBINATES: 
 
Elevations in lateral wall appear by about 9 – 10 weeks as major furrows. It has a 
ascending & desending ramus. 
Maxillo turbinal becomes inferior turbinate 
Ascending ramus  of  1st ethmo turbinal becomes agger nasi 
Desending ramus 1st ethmoturbinal becomes uncinate. 
Ascending ramus of  1st primary furrow becomes frontal recess. 
Desending ramus of 1st primary furrow becomes Hiatus semilunaris and Ethmoidal 
infundibulum.  
2nd ethmoturbinal becomes middle turbinate  
3rd ethmoturbinal becomes superior turbinate . 
4th & 5th  ethmoturbinal fuses to form supreme turbinate . 
Turbinates are really only the ends of bony lamella which traverse the entire ethmoid 
laterally to lamina papyracea  & superiorly to lamina cribrosa. 
1st    lamella  - uncinate 
2nd   lamella – bulla lamella 
3rd    lamella – ground lamella 
4th    lamella – superior turbinate 
5th    lamella – supreme turbinate. 
 (7) 
 
DEVELOPMENT OF LUNGS : 
 
Each  lung  develops from a bud at the lower end of laryngotracheal tube that grows 
down from  the floor of the primitive pharynx. This epithelial buds form only the 
epithelial part of the lung; the connective tissue, cartilage and muscle of  the bronchial 
tree are derived from then surrounding mesoderm. By the 5th month the lung has a 
glandular appearance, with clumps of epithelial cells and hardly any recognizable 
lumina,but the cell group become expanded and lie adjacent to a multitude of capillaries 
so that by the 7th month there are sufficient alveoli to sustain a viable infant following 
premature birth at this time. Surfactant begins to be secreted about the 6th month. 
 
THE LATERAL NASAL WALL: 
 
The inferior meatus is that  part of the lateral wall of the nose lateral to the inferior 
turbinate.It is the largest meatus, extending almost the entire length of the nasal cavity. 
The meatus is highest at the junction of the anterior and middle third.  
 
In adults this ranges from 1.6 to 2.3cm at 1.6cm along the bony lateral wall . The 
nasolacrimal duct opens into the inferior meatus usually just anterior to its highest point. 
There is no true valve, the opening being covered by small folds of mucosa. It can be 
identified in life by gentle massage of the lacrimal sac at the medial canthus. 
 (8) 
Inferior turbinate 
 
This  structure is composed of a separate bone, the inferior concha which has an irregular 
surface, perforated and grooved by vascular channels to which the mucoperiosteum is 
firmly attached.  
 
The bone has a maxillary process  which articulates with the inferior margin of the 
maxillary hiatus. It also articulates with the ethmoid ,palatine and lacrimal bones 
completing the medial wall of the nasolacrimal duct. The inferior concha has its own 
ossification centre which appears around the fifth intrauterine month . 
 
The turbinates possesses an impressive submucosal cavernous plexus with large sinusoids 
under autonomic control which provides the major contribution to nasal resistance. The 
turbinate is covered by respiratory epithelium with a high number of goblet cells which 
decrease in density towards the posterior end. 
 
 
 Middle meatus 
 
The middle meatus is that portion of the lateral nasal wall lying lateral to the middle 
turbinates. It receives drainage from the frontal, maxillary and anterior ethmoidal sinuses.  
 
(9) 
Considerable confusion has arisen with regard to terminology in this area, as many term 
orginally defined in the  last century by the german and french have been used  
interchangeably. In the past when radical sinus surgery was predominantly used for most 
pathology this was of less significance. The advent of endoscopic surgery has led to an 
increased interest in the detailed anatomy of the region and a need for consensus in 
terminology. 
 
The configuration of the structures of the middle meatus are complex and variable, but 
can more readly be understood when the embryological development of the area is 
considered. If the topographical anatomy is considered in the sagittal plane, a number of 
structures are apparent, covered by the middle turbinate in a disarticulated skull the 
maxillary bone has large opening in its medial wall the maxillary hiatus.  
 
In the articulated skull this is filled in by adjacent bones. 
Inferior: the maxillary process of the inferior turbinate bone. 
Posterior: the perpendicular plate of the palatine bone 
Anterosuperior: a small portion of the lacrimal bone. 
Superior: the uncinate process and bulla of the ethmoid. 
 
A portion of the maxillary hiatus is nevertheless left open by these osseous attachments, 
which in life is filled by the mucous membrane of the middle meatus, the mucous 
membrane of the maxillary sinus and the intervening connective tissue-the membranous 
portion of the lateral wall. This membranous area can be defined as lying anterior or  
 (10) 
posterior to the uncinate process ,constituting the anterior and posterior fontanelles 
respectively.  
 
It is in the fontanelles that accessory ostia are found, their formation probably arising as a 
consequence of infection and consequently, they have been compared to perforations in 
the tympanic membrane.  
 
It is difficult to ascertain a natural incidence for accessory ostia but is probably of the 
order 4-5% in the general adult population inceasing to 25% in patients with chronic 
rhinosinusitis. Accessory ostia are found most frequently iin the posterior fontancelle 
which is generally larger than its anterior counterpart. 
 
The uncinate process 
 
This thin crescent of bone curves posteriorly, parallel with the curve of the anterior face 
of the ethmodial bulla. In addition to its anterior attachment to the maxillary hiatus it 
attaches superiorly in a variety of ways.  
 
It may curve laterally to reach the laminapapyracea. It may attach superiorly to the skull 
base or occasionally it may fuse with the insertion of the middle turbinate. In the two 
later situations there is confluence of  drainage from the frontal and maxillary sinuses  
 
(11) 
 
with the ethmoidal infundibulum leading into the frontal recess with obvious potential 
pathological consequences. 
 
When the uncinate process inserts on the lamina papyracea, the ethmoidal infundibulum 
leads superiorly into a blind pouch, the terminal recess . Exceptionally, the unicinate 
process is pneumatized. 
 
The agger nasi 
 
This area has caused considerable confusion but constitutes with the uncinate precess, the 
remnants of  the nasoturbinal  in lower mammals  and  is the most anterior part of the 
ethmoid. It is represented  by a small crest or mound on the lateral wall just anterior to 
the attachment of the middle turbinate .  
 
It is occasionally pneumatized, though the incidence in the normal population is probably 
less than 5%. Pneumatization  of the agger nasi region may encroach upon the 
nasolacrimal duct. 
Hiatus semilunaris 
The hiatus semilunaris is a two dimensional space lying between the posterior edge of the 
unicate process and the anterior surface of the ethmoidal bulla. The ethmoidal 
infundibulum is reached from the middle meatus by passing through the hiatus 
semilunaris. 
 (12) 
Ethmodial infundibulum 
 
The ethmodial infundibulum is a three- dimensional funnel connecting the natural ositum 
of the maxillary sinus to the middle meatus via the hiatus semilunaris. It is defined: 
Medial:uncinate process and hiatus semilunaris 
Lateral:lamina papyracea 
Anterior:an acute-angled blind recess where the uncinate process meets the lamina 
papyracea. 
Posterior:anterior face of the ethmoidal bulla 
Superior:this will vary according to the attachment of the uncinate process. 
Anteriorly the uncinate process may be separtated by      only 1-2 mm from the lamina 
papyracea for some distance before they join. 
The natural ostium of the maxillary sinus lies in the floor of the ethmodial infundibulum 
usually at th junction of its middle and posterior  third and so is not readily visualized 
until the unicinate process has been removed. 
 
The frontal recess 
The frontal recess is found in the most anterosuperior portion of the middle meatus.The 
term frontonasal duct has been generally abandoned as no true duct exists either 
histologically or topographically in most people. The natural ostitum of the frontal sinus 
is somewhat variable in its configuration but most frequently it presents  as an hour-glass   
 
(13) 
narrowing opening directly into the recess. Rarely a longer narrowed  region is found.in 
10 % of patients ,mutiple ostia are found , though these openings should not be confused 
with more laterally placed supra bullar cell running in to orbital roof.  
 
BOUNDARIES OF FRONTAL RECESS  
• Laterally , lamina papyracea. 
• Medially , middle turbinate.                      
• Superiorly, skull base. 
• Inferiorly  and anteriorly, roof and posterior wall of ethmoidal bulla. 
• Posteriorly , basal lamella of middle turbinate. 
The ethmoidal bulla 
This is one of the most constant features in the middle meatus containing the largest 
anterior ethmoidal cell . 
 It may be poorly aerated or completely unpneumatised in 8 % of patients  and it is 
called as  Torus lateralis. 
The anterior face forms posterior margin of the hiatus  semi lunaris and ethmoidal 
infundibulum. Posteriorly the bulla may fuse with the basal  lamella of the middle 
turbinate and superiorly it may reach the roof of ethmoid forming the posterior wall 
of  frontal recess.  
 
(14) 
Sometimes a cleft is encountered  between the posterior wall of bulla and the basal     
lamella of the middle turbinate , the lateral sinus or recessus supra ethmoidalis. If the  
bulla does’t reach the skull base lateral recess will connect  above the bulla with 
frontal recess anteriorly. 
      
      Anatomical variations 
 
There is a considerable range of anatomical variation in  this area which has been 
implicated in the aetiology of sinus infection.This includes pneumatization of the 
middle turbinate , enlargement of the ethmoidal bulla, a paradoxically bent middle 
turbinate, everted uncinate process and the presence of haller cells or a septal 
deflection.  
 
The incidence with which these are seen in a normal population may appear to be less 
frequent than in those individuals with chronic rhinosinusitis but no closer inspection 
it is clear that it is narrowing of the ostiomeatal complex rather than the existence of 
the variant which is the important factor. 
 
(15) 
Superior meatus 
This meatus is again defined by its relationship to the superior turbinate . The 
Posterior Ethmoidal cell open into the region. A Supreme turbinate is discernible 
above  the superior meatus in 60-67% of subjects,though is well developed in less 
than 20%.  
Drainage to the corresponding supreme meatus from the posterior ethmoidal system 
can take place under these circumstances. 
 
Sphenoethmoidal recess 
The sphenoethmoidal recess lies medial to the superior turbinate and is the location of 
the ostium of the sphenoid sinus. 
 
      Histology of the lateral wall : 
The majority of the lateral wall is covered by respiratory ciliated columnar epithelium 
though there is a small variable area superiorly of olfactory epithelium spreading  
down from the cribriform plate. Areas of squamous metaplasia are often found on the 
lateral wall, particularly in areas subjected to greatest airflow such as the anterior end 
of inferior turbinates. 
 (16) 
ARTERIAL SUPPLY : 
• Sphenopalantine artery 
• Greater palantine artery 
• Anterior ethmoidal artery 
• Posterior ethmoidal artery 
 
VENOUS DRAINAGE: 
• Ethmoidal vein 
• Facial vein 
• Sphenopalatine vein 
 
NERVE   SUPPLY : 
• Anterior ethmoidal nerve 
• Branches of sphenopalantine ganglion 
• Greater palantine nerve 
• Anterior superior alveolar nerve. 
 
(17) 
NASAL EPITHELIUM : 
Within the epithelium three types of cells are identified 
• Basal cells  lying on the basement membrane 
• Ciliated columnar cells 
• Goblet cells 
 
 
NASAL SUBMUCOSA: 
Nasal submucosa  lies beneath basement membrane and contains a host of cellular 
components in addition to nasal glands, nerves and blood vessels. In light microscopy 
of nasal biopsy the predominant cell in the submucosa was mononuclear cells. Three 
types of nasal glands are present, 
1. anterior serous glands 
2. seromucous glands 
3. intraepithelial glands. 
 
 
 
 
(18) 
BRONCHOPULMONARY SEGMENTS 
a.   Right upper lobe                                                a.  Left upper lobe 
1.  Apical segment                                                  1.Apicoposterior segment 
2.  Posterior segment                                               2.Anterior segment 
3.  Anterior segment 
b.  Right middle lobe                                               b. Lingula 
1.  Lateral segment                                                 1.Superior segment 
2.  Medial segment                                                  2.Inferior segment 
c.  Right lower lobe                                                c.Left lower lobe 
1. Apical segment                                                   1.Apical segment  
2. Medial basal segment                                          2.Medial basal segment 
3. Anterior basal segment                                         3.Anterior basal segment 
4. Lateral basal segment                                            4.Lateral basal segment     
5. Posterior basal segment                                         5. Posterior basal segment 
 
(19) 
Structure of Broncho Pulmonary Segment: 
Bronchi have smooth muscle and hyaline cartilage in their walls and are lined by the 
typical respiratory type of epithelium pseudostratified ciliated columnar with mucous 
glands. By successive divisions they become smaller and smaller, when cartilage 
disappears(at a diameter of about 1 mm ) bronchi become bronchioles. The more distal 
divisions of bronchioles, where cilia begin to disappear, are respiratory bronchioles, so 
called because some alveoli(air sacs) open off them. The bronchioles just proximal to 
respiratory bronchioles are rather confusingly called terminal bronchioles.Beyond the 
respiratory ducts with many alveoli opening off them,and these continue in to alveolar 
ducts. 
 
Blood supply : 
The bronchial tree receives  its arterial supply from 3 bronchial arteries, on left side as 
direct branches of aorta and on right side from posterior intercostal  arteries. The 
bronchial veins drain in to azygos vein on the right side and hemiazygos vein on left 
side.Pulmonary artery divides with the bronchus but does not supplies it. It supplies the 
alveoli.  Pulmonary veins does not follow the bronchi but runs in the intersegmental 
septa. 
(20) 
PHYSIOLOGY OF AIRWAY 
PHYSIOLOGIC FUNCTIONS OF THE NOSE: 
1.Respiration  
• Heat exchange 
• Humidification  
• Filtration  
• Nasal resistance 
• Nasal fluids & ciliary function 
• Neurovascular reflexes 
• Voice modification  
2.Olfaction . 
Nose   modifies   the  air   so  that  gas  exchange  in  alveoli  can  be  achieved  
without damaging   it. During  inspiration  the  air  flow  is  opposite  to  the    
direction  of  blood flow,  thus  it  is  more  efficient  in  warming  inspired  air. 
Inspired air is warmed from a temperature  of   around  20o c  to  31 oc  in  the  
pharynx  and  35 oc  in  the  trachea. 
 
 
(21) 
As the expiratory air passes through the nose, it gives up heat to the cooler nasal 
mucosa and the temperature falls  so that water condenses on it. 
During inspiration the  airflow is directed upwards and back wards mainly over 
the anterior end of the inferior turbinate. It divides it in to two above and below 
the middle turbinate rejoining in the choanae. Its considered to be laminar, though 
practically its turbulent in the olfactory  region. During Expiration ,air flow is 
turbulent with eddy currents. 
 
NASAL RESISTANCE 
Nose accounts for half of the total airway resistance.  The resistance is important 
during  expiration since the positive pressure is transmitted to the alveoli & keeps 
the lung expanded. The air flow  &  nasal resistance are  modified by mucosal 
changes during nasal cycle. Cyclical changes take place every 4 – 12hrs. They are 
constant for each person and nasal cycle is controlled by autonomic nervous 
system. 
(22) 
PROTECTION  OF LOWER AIRWAY 
Mechanical & chemical protection of the lower airway is one of the major 
functions of the nose. Nose is able to remove particles of 30microns(or) more 
from air. 
 
NASAL SECRETIONS  
• Water & ions from transudation. 
• Glycoprotein: Sialomucins, fucomucins,Sulfomucins. 
• Enzymes: Lysozymes,Lactoferrin. 
• Immunoglobulin: 1gA,IgE, IgG, IgM, IgD. 
• Circulatory proteins:Complement, alpha2  macroglobulin 
 
Lactoferrin acts by binding to divalent metal ions & prevents the growth of certain 
bacteria particularly staphylococcus and pseudomonas. 
 
 
 
(23) 
Principles of secretion transport: 
Drainage and ventilation are two important functions in the maintence of normal 
physiology of paranasal sinuses and their mucous membrane . Normal drainage of the 
Paranasal Sinuses is a complex function of both the secretion and transport 
mechanisms,and to a larger extent dependent on the amount of mucus produced,its 
composition ,effectiveness of ciliary beat and condition of the ostia and the ethmoidal 
clefts in to which respective sinus ostia opens. 
In health the mucous blanket that covers the nasal mucosa is continuosly produced by 
sreomucinous glands & intraepithelial goblet cells.This mucus film has 2 layers:an inner 
serous layer, called sol phase, in which cilia beat   and outer more viscous layer gel 
phase. 
Normal nasal mucous exists in equilibrium between the sol layer and gel layer at a pH   of 
7.5-7.6.A proper balance between the inner sol phase and outer gel phase is of critical 
importance for normal mucociliary clearance. 
Dust particles are incorporated in to the gel phase and toghether with the gel phase 
transport out of  the sinuses in normal conditions.Under abnormal conditions pathogens 
may be incorporated in to cells of mucosa. 
An unimpeded flow of air during inspiration through the nose is further a factor since 
forced inspiration  creates suction or negative pressure that promotes transportation of 
mucous out of the sinuses. 
(24) 
The cilia beat in a synchronised(transversally) and metachronised(longidudinally) 
manner.The cilia move almost exclusively in the sol phase of secretion.The gel phase is 
actively transported over the sol phase like a carpet during their active cilia beat; there is 
no contact between the cilia and the gel phase during the recovery phase. 
 
Under normal conditions, the mucous layer is steadily transported away.Endoscopic 
studies indicate that a healthy maxillary sinus renew its mucus layer every 20 to 30 
minutes. 
 
Bony crests,found protruding in to the lumen of the frontal sinuses are usually traversed 
by the secretions with out any problem.If the secretions becomes more viscous and 
consequently thicker and heavier,however ,these crests may become a obstacle to mucus 
transport and the secretion may be retained at the crest and finally drain away through the 
effect of gravity. 
 
Human nasal and paranasal sinus mucosa and their ciliary activity may survive the death 
of individual for 24 to 48 hours.With progressing dehydration and increasing viscosity of 
the mucous or with the final death of mucosal cells, the ciliary beat ceases. 
 
(25) 
One of the most important of the Messerklinger’ s discoveries following earlier animal 
studies by Hilding was the observation that the secretions of various sinuses do not raech 
the respective ostia  by random fashion,but follow very definite pathways,which seems to 
be genetically determined. 
 
Secretion transport in the maxillary sinus: 
 
In the maxillary sinus secretion starts from the secretion starts in the floor of the 
maxillary sinus in a stellate pattern. The mucuos is transported along the anterior ,medial 
, posterior, and the lateral walls of sinuses as well as along the roof.All the secretions 
converge at the natural ostium of the maxillary sinus. 
 
The maxillary sinus ostium normally opens in to the floor of posterior third of ethmoidal 
infundibulum.Secretion from the sinus is always transported via the natural ostium even 
when there is  one or more accessory ostium in the area of the fontanelles and even in the 
patients in whom a patent window in the inferior meatus is created. 
While the inferior meatal antrostomy can provide ventilation to the diseased sinuses and 
consequently may help normalise the sinus, these inferior meatal  antrostomy do not 
achieve considerable active outwardly directed transport of secretions. 
(26) 
Secretion transport in frontal sinus: 
In the frontal sinus there is an active inwardly directed transport of mucous.along the 
interfrontal septum,mucus is transported in to the frontal sinus,then laterally along the 
roof and back medially via the floor and the inferior portion of the posterior and the  
anterior wall of the sinus.The secretion then exits the frontal sinus after one round 
trip.This is the result of a whorl- like motion in the ciliary pattern. 
 
An isolated mucosal lesion as long as it does not obstruct the ostium usually does not 
obstruct mucus transport.If however the mucosal surfaces come in direct contact with 
each other, a Bridging Phenomenon may occur, with more serous component of the 
mucus remaining in the recess.Even though the drowned cilia beat in vain ,the gel phase 
is transported because of its cohesion. 
 
 
 
 
 
 
 
 
 
 
(27) 
NASAL IMMUNE SYSTEM 
1. Surface properties 
2. Mechanical 
Physical characteristics of mucus  
3.Innate immunity 
a) Bactericidal activity of mucus 
b) Proteins: Lactoferrin, lysozymes, Macroglobulin. 
c) C reactive Protein, Complement system. 
            d) Cellular: Polymorphs and macrophages. 
4.Acquired immunity 
  a) Surface 1gA, IgM, IgE &IgG 
  b) Lymphocytes – Mucosal associated lymphoid tissue  
5.Distant sites 
    Adenoids & lymph nodes  
 
(28) 
NASOPULMONARY REFLEX: 
Increased air flow through one side of the nose is associated with increased ventilation of 
homolateral lung. Blowing of air through a nostril causes bronchial muscle to relax on the 
same side and increase its respiratory activity. 
 
THE POSSIBLE FUNCTIONS OF PARANASAL SINUSES: 
1.Vocal  resonance and diminution of auditory feedback . 
2.Air conditioning. 
3.Pressure damper. 
4.Reduction of skull weight. 
5.Mechanical rigidity. 
6.Heat insulation. 
7.Increasing the olfactory area. 
 
 
(29) 
PULMONARY VOLUMES(11). 
Tidal volume is the volume of air inspired (or) expired with each normal breath. It 
amounts to about 500ml in the adult male. 
The inspiratory reserve volume is the extra volume of air that can be inspired over and 
above the normal tidal volume, when the person inspires with fullforce and it is usually 
equal to about 3000ml. 
The expiratory reserve volume is maximum extra volume of air that can be expired by 
forceful expiration, normally about 1100ml. 
The residual volume is the volume of air remaining in the lungs after the most forceful 
expiration and it averages about 1200ml. 
PULMONARY CAPACITIES 
The inspiratory capacity equals the tidal volume plus inspiratory reserve volume . This is 
the amount of air a person can breathe in  beginning at the normal expiratory level and 
distending the lungs to maximum amount. It averages about 3500ml. 
The functional residual capactiy equals the expiratory reserve volume plus the residual 
volume. This is the amount of air that remains in the lungs at the end of normal expiration 
and it is about 2300ml. 
The vital capacity = Inspiratory Reserve vol.+Residual vol. +expiratory reserve vol.                   
 (30) 
This is the maximum amount of air a person can expel from the lungs after filling the 
lungs to their maximum extent in then expiring to maximum extent. 
The total lung capacity is the maximum volume to which the lungs can be expanded with 
the greatest possible effort (5800ml) it is equal to the vital capacity  + residual volume. 
Minute Respiratory volume = Respiratory rate x  Tidal Volume. 
Minute Respiratory volume =  12 x 500ml = 6000ml/min. 
ALVEOLAR VENTILATION: 
Alveolar ventilation is the  rate at which new air reaches the alveoli, alveolar sacs, 
alveolar ducts and respiratory bronchioles. 
Alveolar ventilation  = Respiratory rate x (tidal volume –dead space air) 
                      = 12 x (500 –150ml) =4200ml/min. 
DEAD SPACE AIR : 
Some of the air a person breathes never reaches the gas exchange areas but fills 
respiratory passages where gas exchange doesn’t occur such as the nose , Pharynx & 
trachea.This air is called dead space air because it is not useful for gas exchange and the 
normal dead space air is about 150ml. 
(31) 
To keep the trachea from collapsing ,multiple cartilage rings extend above 5/6 of the 
wayaround the trachea. In the walls of the bronchi, less extensive curved cartilage plates 
alsomaintain a reasonable amount of rigidity yet allow sufficient motion for the lungs to 
expand. The bronchioles are not prevented from collapsing by rigidity of their wall 
instead they are kept expanded by transpulmonary  pressure that expand the alveoli. 
 
In all areas of the trachea & bronchi not occupied by cartilage plates the walls are 
composed  mainly of smooth muscle. Also the walls of the bronchioles are almost 
entirely smooth muscle, with the exception of the most terminal bronchiole called 
respiratory bronchiole which is mainly composed of pulmonary epithelium & under lying 
fibrous tissue. 
 
Under normal respiratory conditions air flow through the respiratory passage ways so 
easily that less than 1cm of water pressure gradient from the alveoli to the atmosphere is 
sufficient to cause enough airflow for quite breathing. The greatest amount of resistance 
to airflow occur not in the minute air passage of terminal bronchiole but in some large 
bronchioles, bronchi & near trachea. 
 
 
(32) 
Yet in disease condition the smaller bronchioles often play a for greater role in 
determining airflow resistance because of their small size. 
1.Muscle contration in their walls. 
2.Edema occuring in the walls. 
3 Mucus collecting  in the lumen of the bronchioles & Parasympathetic          
constriction    of the bronchioles . 
 
 
 
 
 
 
 
 
 (33) 
PATHOPHYSIOLOGIC MECHANISMS 
WHO definition of Bronichal asthma(8): 
Bronchial asthma is a chronic inflammatory disorder of the airways in which cellular 
elements play a role, in particular mast cells ,eosinophils, T lymphocytes macrophages, 
neutrophils and epithelial cells. In susceptible individuals this inflammation causes 
recurrent episodes of wheezing, breathlessness, chest tightness and coughing .These 
sysmptoms usually associated with widespread but variable airway obstruction that is 
often reversible either spontaneously (or) with treatment. The inflammation also causes 
an associated increase in existing bronchial hyper responsiveness to a variety of stimuli. 
SYMPTOMS OF ASTHMA 
• Wheeze  
• Chest tightness 
• Cough 
• Breathlessness. 
TYPES OF BRONCHIAL ASTHMA: 
Extrinsic- in which identifiable external trigger factor are present. 
Intrinsic- in which no such factors are identified. 
(34) 
OVERVIEW  OF PATHOLOGICAL CHANGES IN ASTHMA: 
• Edema of the airway wall . 
• Shedding of the airway epithelium. 
• Mucus plugging of the airway lumen  
• Thickening of the reticular layer of basement membrane. 
• Goblet cell hyperplasia 
• Neovascularisation  
• Vasodilatation in the smooth muscle layer . 
• Hyperplasia &hypertrophyof airway smooth muscle. 
• Mucosal gland hypertrophy. 
• Ultimately the development of irreversible fibrosis. 
CURRENT VIEW OF MECHANISMS IN ASTHMA. 
Asthma is now viewed as a complex inflammatory condition involving many 
inflammatory cells which release a wide variety of mediators. These mediators act on 
cells of the airway leading to potentially reversible abnormalities including smooth  
muscle contraction ,mucus hypersecretion,plasmaleakage,edema,activation of cholinergic 
reflexes and activation of sensory nerves. 
Chronic inflammation leads to structural changes including goblet cell hyperplasia,new 
vessel formation ,subepithelial fibrosis, smooth muscle hypertrophy and hyperplasia 
(35) 
SINUS & BRONCHIAL SIMILARITIES 
1. Atmospheric exposure 
2. Ciliary epithelium 
3. Goblet cells producing mucus 
4. Aerosols (Infection (or)allergens) trigger pathogenic events 
5. Defence mechanism. 
6. Eosinophilic inflammation. 
SINO PULMONARY DISORDERS 
1. Sino bronchial allergy 
2. Sinopulmonary syndrome 
• Sinobronchial allergic mycosis 
• Primary ciliary dyskinesia 
• Wegener granulomatosis 
• Churg strauss syndrome. 
3. Cystic fibrosis 
 
 
 
 
(36) 
The frontal and the maxillary sinuses are dependant  sinuses, subordinate to the their 
prechambers in the ethmoid and lateral nasal wall.Drainage and ventilation are 
essential for the normal funtioning of the sinuses.The ventilation and drainage of the 
maxillary and the frontal sinuses pass through very narrow and complicated clefts 
before they reach the free middle meatus. 
 
Those disorders which produce any additional stenosis of these narrow key areas 
resulting in  the contact areas  of the opposing mucosa with mucuos retention .If  
infected smaller or larger areas of chronically diseased mucosa may 
persist.Frequently these areas of intimate contact can be identified as the site of origin 
of polyps. 
 
Messerklinger noted that limited resection of disease in the key areas and 
reestablishment of drainage and ventilation via natural pathways,even massive 
mucosal pathology usually healed  without direct inervention in these sinuses. 
 
 Chronic Rhinosinusitis is defined as inflammation of the mucosal lining of nose and 
sinuses lasting for atleast 12 weeks duration(31). 
 
(37) 
CELLULAR  PATHWAY: 
Chronic sinusitis and asthma are characterised by an inflammatory process that is marked 
histologically by eosinophils.The eosinophils contains major basic protien as well as 
eosinophilic cationic protien both of which contribute to inflammation and injury of 
epithelium of nose , sinuses & lungs. 
Nasal mucosa contain antigen presenting cells, which are similar to dendritic langerhans 
cells . These cells capture and process allergens in nasal mucosa. Immunologic homing 
occurs when T lymphocytes are activated by antigen processing in the PNS & migrate to 
the mucous membranes of adjacent mucosa thereby extending the inflammatory process 
to the lower airway. The release of cytokines recruites other inflammatory mediators to 
the upper & lower airway(13,14,15). 
 
HUMORAL  PATHWAY: 
The direct passage of mediators produced by activated inflammatory cells from the 
sinsuses through postnasal drip exerts a significant effect on bronchial responsiveness(16). 
 
 
 
(38) 
NEURAL PATHWAY: 
The cholinergic pathway has a keyrole in maintaining resting bronchial muscle tone & in 
mediating acute bronchospastic responses(20) . Lungs are innervated by parasympathetic, 
non-adrenergic and noncholinergic autonomic pathway. Receptors in the nose & pharynx 
and presumably in the paranasal sinuses produce afferent fibers that form part of  
trigeminal nerve, which passes to brain stem & connects with the reticular formation of  
dorsal vagal nucleus. From the vagal nucleus, parasympathetic efferent fibers travel in the 
vagus nerve to the bronchi. Development of asthma is associated with cholinergic hyper  
responsiveness and a postulated partial B-adrenergic receptor blockade. Sinusitis may be  
associated with a reversible pre existing partial B-adrenergic blockade that improves with 
treatment of upper airway inflammation. 
The non adrenergic , non-cholinergic nervous system of neuropeptides also contributes to  
lower airway autonomic function. Neuro peptides trigger smooth-muscles  
contraction,vasodilation  plasma extravasation  and mucus hypersecretion(21). 
ROLE OF NITRIC OXIDE. 
The nitric oxide concentration decreases during acute maxillary sinusitis. The nitric oxide  
level returns to base line after sinusitis is  resolved. A reduction in Nitric oxide is a potent 
modulator of bronchial tone may precipitate bronchial hypersecretion(17). 
 
(39) 
MATERIAL AND METHODS 
INCLUSION CRITERIA: 
Patients  referred from Asthma & Allergy clinic as a case of  Bronchial asthma are 
screened for chronic rhinosinusitis. Cases diagnosed a chronic rhinosinusitis are treated 
medically for 3 weeks(23) and those refractory to conservative management are subjected 
to surgical management.  
 
EXCLUSION CRITERIA: 
Patients with chronic obstructive pulmonary disease, cardiac diseases, pulmonary 
tuberculosis, Bronchiectasis, fungal sinusitis & those who have already undergone nasal 
surgeries are excluded from the study. 
 
PLACE OF STUDY  : Government Stanley Medical College,  Chennai. 
PERIOD OF STUDY:  January 2005 to June 2006. 
 
(40) 
MEASURES FOR DIAGNOSING CHRONIC RHINOSINUSITIS (31): 
 
1.Continous symptoms that persist for 12 consecutive weeks or longer and physical 
findings of rhinosinusitis on examination or radiographic sinus imaging. 
 
2.One of these signs of inflammation must be present and identified in association with 
on going symptoms consistent with Chronic Rhinosinusitis: 
 
(A) Discoloured nasal discharge arising from nasal passages,nasal polyps or polypoid 
swelling as identified on physical examination. 
 
(B) Edema or erythema of the middle  meatus or ethmoidal bulla identified on nasal 
endoscopy. 
 
(C) Generalised or localised erythema ,edema or granulation tissue . If the middle meatus 
or ethmoidal bulla is not involved radiologic imaging is required. 
 
(D)Imaging modalities for confirming diagnosis 
 
o CT SCAN demonstrating isolated or diffuse mucosal thickening,bone 
changes,air-fluid level. 
o Plain sinus radiograph (Waters view) revealing mucous membrane 
thickening of 5 mm or greater or complete opacification of one or more 
sinuses. 
o MRI is not recommended as an alternative to CT scan for routine 
diagnosis of Chronic rhinosinusitis because of its high sensitivity but lack 
of specificity. 
 
(41) 
METHOD OF SCREENING-TASK FORCE ON RHINOSINUSITISCRITERIA 
Major criteria:  
Facialpain/pressure.  
Facialcongestion/fullness. 
Nasalblock 
Nasaldischarge 
Hyposmia/anosmia 
Purulence in middle meatus on anterior rhinoscopy 
Fever (acute rhinosinusitis) 
Minor criteria 
Headache 
Halitosis 
Fatigue 
Dentalpain 
Cough 
Earpain  &  Fever(non-acute) 
  
 
 
(42) 
 
For diagnosis 2major or 1 major &2 minor or purulent discharge in middle meatus alone 
are required(26) 
 
 
X- ray paranasal sinuses waters view taken for those patients diagnosed as rhinosinusitis 
case and then they are subjected to diagnostic nasal endoscopy under local anesthesia.   
Cotton pledgets are soaked in the mixture of 10ml of 4% lignocaine with 1ampoule of 
1:1000 epinephrine . The cotton pledgets are placed in the middle meatus till the end of 
the middle turbinate  to block sphenopalantine branches, another pledget in the 
sphenoethmoidal area filling the space between the septum and middle turbinate  . A 
pledget in the floor of the nasal cavity .After 10minutes, DNE was done using 0o  and 30 o 
rigid nasal endoscope .  
 
3 steps of systematic examinations in each pass  was done. In  First pass , endoscope is 
passed beneath the inferior turbinate parallel to the floor of the nose into the postnasal 
space. Adenoids and orifice of the eustachian tube can be seen clearly. Fossa of 
Rossenmuller is seen just behind & above eustachian orifice as a recess. 180o rotation 
longitudinally in the opposite direction reveals contralateral side structures.The upper 
surface of the soft palate can be clearly seen as floor. Hasner’s valve,guarded by one or 
two mucosal folds around the opening of the nasolacrimal duct is located laterally at  the 
highest anterior point of the inferior meatus.  
 
In Second pass,endoscope is guided past beneath the middle turbinate to the upper edge 
of the choana to look up into the area of sphenoethmoidal recess. It can sometimes be 
difficult to get a good view with 4mm scope.Superior turbinate,sometimes supreme 
turbinate & natural sphenoid ostium can be visualized. In Third pass endoscope is passed 
into middle meatus between the middle turbinate & lateral wall of the nose Uncinate 
process would be lateral to middle turbinate &bulla can be seen behind it.           
 
 
(43) 
 
Maxillary  ostium is situated at a 15 o angle to the vertical plane anteroinferior to the 
lower anterior margin of bulla, in the infundibulum obscured by hooding uncinate 
process.   Any discharge in the middle meatus, sphenoethmoidal recess, accessory  
ostium,polyps,polypoidal mucosa and anatomical variants like medialised uncinate, 
prominent agger nasi etc., are observed and recorded . 
 
Patients are managed with antibiotics, antihistamines, decongestant nasal drops and steam 
inhalation for a period for 3 weeks and CT  PNS taken after that. Evidence of  sinusitis 
observed in CT Scan.  Patients refractory to conservative management are subjected to 
surgical management . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
XRAY   PARA NASAL  SINUSES  WATERS  VIEW 
WITH  EVIDENCE  OF SINUSITIS 
 
 
                                
                                         Haziness in left maxillary sinus.                                        
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EVALUATION  
Patients with Bronchial asthma & Chronic rhinosinusitis are evaluated pre-
operatively and post-operatively as follows: 
API GUIDELINES OF GRADING ASTHMA 
Class Diurnal symptoms Nocturnal symptoms 
Mild intermittent <2attacks in a week 
asymptomatic in between. 
<2attacks in a month. 
Mild persistent  >2attacks in a week but <1 in 
a day 
>2attacks in a month 
moderate persistent Daily symptoms exacerbations 
>2 in a week 
>1 attack in a week 
severe  persistent Continoussymptoms& 
frequent exacerbations 
 
 
Scoring system for individual symptoms of Asthma and Rhinosinusitis: 
0-No symptoms 
1-mild symptoms, normal activities not affected. 
2-moderate symptoms, slight disturbance in normal activities 
3-severe symptoms, serve disturbance in normal activites 
4-very severe symptoms unable to work. 
Asthma symptoms:Dyspnea & Wheeze. 
Sinusitis symptoms:Nasal discharge, Hyposmia, Facialpain,Headache& Nasal block 
(45) 
PEAK  EXPIRATORY  FLOW  RATE (PEFR) 
Expiratory peak flow (PEF) is the maximum flow generated during expiration performed  
with maximal force and started after a full inspiration . PEF is appreciably larger if the  
maneuver is performed without pause immediately after the inspiration than if it is  
performed after a pause . Contrary to popular belief PEF is not effort dependent if the   
maneuver is performed sufficiently forcefully in most subjects PEF is determined by flow  
limitation in central, possibly also in more peripheral airways . 
Report the largest value of 3 correctly performed maneuvers, but the difference  
between the largest two should be less than 40 L/min; if the difference is larger then have 
up to 2 extra efforts performed. If even then the two largest values differ by > 40 L/min, 
then report the largest one with a note to the effect that  reproducible measurements could 
not be obtained. The best reference value for a subject is produced when he is  in a 
clinically good condition.  
PEF is not often used to assess bronchodilator responsiveness. An increase in PEF  by 
60 L/min or more in adults has been regarded as a sign of significant  improvement An 
abnormally low PEF may be due to obstructive lung disease,unsatisfactory cooperation, 
prior inhalation not to total lung capacity restricted lung expansion (stiff chest cage, 
muscular or neurogenic disorder). 
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EXPECTED FORMULA FOR PEFR. 
FOR  MALES. 
Age in yrs 7 – 15 yrs 16 – 40 yrs 40 yrs < 
Formula (5 x ht.in cms) – 
420 
(2.74 x ht.in cms) + 
53.4 
567 – (2.24 x age) 
Normal range 80-450 L/min 400 –650 L / min 300 – 500L/min. 
 
 
FOR  FEMALES. 
Age in yrs 7 – 15 yrs 16 – 40 yrs 40 yrs < 
Formula (5 x ht.in cms) – 
430 
(4.65 x ht.in cms) – 
360 
438 – (2.24 x age) 
Normal range 70-400 L/min 250 –400 L / min 200 – 400L/min. 
 
 
Grading asthma on the basis of PEFR 
 PEAK EXPIRATORY FLOW RATE GRADE OF ASTHMA 
>80% of expected PEFR MILD 
60-80% of expected PEFR MODERATE 
<60% of expected PEFR SEVERE 
 
 
 PORTABLE WRIGHTS PEAK FLOW METER. 
 
 
                                               
 
A PATIENT USING PEAK FLOW METER. 
 
                             
 
 (47) 
107 patients (88 females & 19 males) with age distribution of (10– 70 yrs) are screened 
for chronic rhino sinusitis using TASK FORCE RHINOSINUSITIS 
CRITERIA(Lanza&Kennedy). 53 pts  clinically diagnosed to have rhinosinusitis are  
further evaluated using Diagnostic nasal  endoscopy and  x-ray of paranasal sinuses 
waters view.  47 cases diagnosed as having  chronic rhinosinusitis are treated with 
antibiotics, antihistamines, decongestant nasal  drops, steam inhalation for a period of 
3wks(23) and CT scan taken after medical treatment . 26 patients found to have 
abnormality in CT PNS after  medical treatment are  considered to be refractory to 
conservative management and subjected to functional endoscopic sinus surgery. 
 
 Likert symptom scale for asthma & sinus symptoms are taken before and after  surgery.  
PEFR  is  used  to  assess   the lung  function  of   patients  periodically  
(1stmonth,2ndmonth&3rdmonth) after treatment .Functional endoscopic sinus surgery 
was performed under general anaesthesia. Pre operatively injection Deriphylline and 
injection Dexamethasone were given intravenously. Considering the possiblity of  
bronchospasm due to anxiety,aspiration of secretions and blood in  local anaesthesia,  
general anaesthesia is preferred. 
Group 1 : Those Patients with asthma and rhinosinusitis managed surgically(n – 26). 
Group 2: Patients with asthma and rhinosinusitis managed conservatively (n - 21). 
Group 3 :Patients with asthma alone selected randomly as controls( n- 30). 
  
STATISTICAL ANALYSIS OF RESULTS. 
ANALYSIS OF PATIENTS IN GROUP 1  
Patients  Sl 
no. 
Age in yrs  / 
sex 
Height in 
cms. 
Normal 
PEFR L/min. 
Pre-operative 
PEFR L/min. 
Post-
operative 
PEFR L/min. 
 %of 
improvement in 
PEFR 
1 40/F  140 291 200 (68.7%) 300(103.09%) 34.39 
2 19/F 142 300 200 (66.6%) 300    (100.%) 33.4 
3 35/F 145 314 250 (79.6%) 400(127.38%) 47.78 
4 23/F 140 291 250 (85.9%) 350     (120%) 34.1 
5 20/F 140 291  200 (68.7%) 300     (103%) 34.3 
6 44/F 150 340 200 (58.8%) 300  (88.23%) 29.43 
7 33/F 150 338 250 (73.96%) 400(118.34%) 44.38 
8 30/F 140 291 250 (85.91%) 350 (120.2%) 34.29 
9 38/F 158 365 200 (54.79%) 400(109.59%) 54.8 
10 16/F 150 338 200 (59.17%) 400(118.34%) 59.17 
11 40/F 142 300 200 (66.66%) 350(116.66%) 50 
12 24/F 156 365 250 (68.49%) 450(123.28%) 54.79 
13 33/F 145 314 250 (79.6%) 400(127.38%) 47.78 
14 30/F 140 291 250 (85.9%) 350 (120%) 34.1 
15 38/F 142 300 200 (66.66%) 350(116.66%) 50 
16 36/F 150 338 200 (59.17%) 400(118.34%) 59.17 
17 40/F 142 300 200 (66.66%) 400(133.33%) 66.73 
18 30/M 150 464 300 (64.65%) 500  (107.7%) 43.05 
19 43/F 140 291 200 (68.7%) 350  (120.2%) 51.5 
20 27/F 142 300 250 (83.33%) 400  (133.3%) 49.97 
21 27/F 150 338 200 (59.17%) 450(133.13%) 73.96 
22 40/F 164 402 200 (49.75%) 400   (99.5%) 49.75 
23 26/F 140 291 200 (68.7%)  300(103.09%) 34.39 
24 39/F 145 314 200 (63.69%) 300    (99.5%) 35.85 
25 25/F 142 300 200 (66.6%) 400(133.33%) 66.73 
26 40/F 142 300 200 (66.6%) 300(103.09%) 36.49 
 Total average of improvement  in PEFR after surgical management            46. 55 % 
  
 
ANALYSIS OF PATIENTS IN GROUP 2 
Patients  Sl 
no. 
Age in yrs  / 
sex 
Height in 
cms. 
Normal 
PEFR L/min. 
Pre-operative 
PEFR L/min. 
Post-
operative 
PEFR L/min. 
 %of 
improvement in 
PEFR 
1 20/F 142 300 200 (66.6%) 300 (100%) 33.4 
2 37/M 160 492 250 (50.8%) 350 (71.14%) 20.34 
3 15/M 156 360 200 (55.5%) 300 (83.3%) 27.8 
4 55/F 150 317 200 (63.1%) 250 (78.86%) 15.7 
5 30/M 146 453 300 
(66.225%) 
400 (88.3%) 22.07 
6 50/M 150 455 250 (54.94%) 350 (76.9%) 21.96 
7 25/F 142 300 200 (66.6%) 250 (83.33%) 16.73 
8 27/M 146 453 300 (66.23%) 450 (99.3%) 33.07 
9 38/F 140 291 150 (51.5%) 250 (85.9%) 34.4 
10 45/F 150 317 200 (63.1%) 250 (78.9%) 15.8 
11 17/F 142 300 150  (50%) 250 (83.3%) 33.3 
12 54/F 150 317 200 (63.1%) 300 (94.63%) 31.53 
13 34/F 142 300 250 (83.3%) 300 (100%) 16.7 
14 30/F 150 338 200 (59.17%) 300 (88.75%) 29.58 
15 25/F 140 291 200 (68.7%) 250 (85.91%) 17.2 
16 
 
18/F 142 300 200 (66.6%) 300 (100%) 33.4 
17 30/F 146 319 250 (78.8%) 350 (109%) 30.2 
18 27/F 140 291 200 (68.7%) 250 (85.9%) 17.2 
19 23/F 142 300 250 (83.3%) 300 (100%) 16.7 
20 37/F 140 291 200 (68.7%) 250 (85.9%) 17.2 
21 51/M 150 455 250 (54.9%) 400 (87.9%) 33 
Total average of improvement  in PEFR after surgical management             24.63 % 
 
 
  
ANALYSIS OF PATIENTS IN  GROUP 3 
 
Patients  Sl 
no. 
Age in yrs  / 
sex 
Height in 
cms. 
Normal 
PEFR L/min. 
Pre-operative 
PEFR L/min. 
Post-
operative 
PEFR L/min. 
 %of 
improvement in 
PEFR 
1 23/F 140 291 200 (68.7%) 200 (68.7%) 0 
2 52/F 152 321.52 150 (46.65%) 200 (62.22%) 15.57 
3 38/F 142 300 200 (66.6%) 250 (83.33%) 16.67 
4 20/F 146 319 200 (62.69%) 200 (62.69%) 0 
5 25/M 146 453.44 300 (66.16%) 300 (66.16%) 0 
6 38/F 150 337.5 200 (59.25%) 200 (59.25%) 0 
7 22/M 150 464.4 300 (64.59%) 250 (53.83%) -10.76 
8 20/F 140 291 150 (51.54%) 150 (51.54%) 0  
9 40/F 142 300 250  (50%) 200 (66.66%) 16.66 
10 42/F 140 343.9 200 (58.15%) 200 (58.15%) 0 
11 40/F 148 328.2 200 (60.94%) 250 (76.17%) 15.23 
12 20/M 145 450.7 300 (66.56%) 300 (66.56%) 0 
13 45/F 143 337.2 150 (44.5%) 200 (59.31%) 14.81 
14 20/F 140 291 150 (51.55%) 250 (85.91%) 34.36 
15 40/F 164 402.6 200 (49.67%) 300 (74.51%) 24.87 
16 29/F 158 374.7 150  (40%) 200 (53.37%) 13.37 
17 30/F 150 337.5 200 (59.25%) 200 (59.25%) 0 
18 29/F 140 291 150 (51.54%) 150 (51.54%) 0 
19 35/F 146 453.4 300 (66.16%) 300 (66.16%) 0 
20 36/F 142 300 200 (66.66%) 250 (83.33%) 16.67 
21 30/F 141 295.65 200 (67.64%) 200 (67.64%) 0 
22 32/F 145 314.25 150 (47.73%) 200 (63.64%) 15.91 
23 44/F 147 339.44 200 (58.02%) 250 (73.65%) 14.73 
24 38/F 141 295.65 250 (84.55%) 200 (67.64%) -16.91 
25 30/F 158 374.7 250 (66.72%) 300 (80.06%) 13.34 
26 42V 143 343.92 300 (87.22%) 300 (87.22) 0 
27 35/F 150 337.5 200 (59.25%) 200 (59.25%) 0 
28 14/F 138 260 150 (57.69%) 200 (76.92%) 19.23 
29 59/F 141 305.84 200 (65.39%) 200 (65.39%) 0 
30 46/F 147 334.96 200 (59.70%) 250 (74.6%) 14.93 
Total average of improvement  in PEFR in control group                       =  7.29 % 
 STANDARD DEVIATION OF  MEAN VALUE OF GROUP 1 
Sl.no %of improvement 
in PEFR x1 
Arithmetic 
mean x2 
Deviation from 
mean(x1- x 2 ) 
(x1-x2)2 
1 34.39 46.55 -12.16 147.87 
2 33.4 46.55 -13.15 172.92 
3 47.78 46.55 1.23 1.51 
4 34.1 46.55 -12.45 155 
5 34.3 46.55 -12.25 150.06 
6 29.43 46.55 -17.12 293.09 
7 44.38 46.55 -2.17 4.70 
8 34.29 46.55 -12.26 150.30 
9 54.8 46.55 8.25 68.06 
10 59.17 46.55 12.62 159.26 
11 50 46.55 3.45 11. 90 
12 54.79 46.55 8.24    67.89 
13 47.78 46.55 1.23 1.51 
14 34.1 46.55 -12.45 155 
15 50 46.55 3.45 11.90 
16 59.17 46.55 12.62 159.26 
17 66.73 46.55 20.18 407.23 
18 43.05 46.55 -3.50 12.25 
19 51.5 46.55 4.95 24.50 
20 49.97 46.55 3.42 11.69 
21 73.96 46.55 27.41 751.30 
22 49.75 46.55 3.20 10.24 
23 34.39 46.55 -12.16 147.86 
24 35.85 46.55 -10.7 114.49 
25 66.73 46.55 20.18 407.23 
26 36.49 46.55 10.06 101.20 
 
 
                                                                                  (x1-x2) 2         =              3698.16                           
                                                                                       n1-1                              25                                  
                  STANDARD DEVIATION OF MEAN VALUE GROUP I   =  12.16 
  
                                                                                                                                                                                        
STANDARD DEVIATION OF  MEAN VALUE OF GROUP 2 
 
 
Sl.no % of improvement 
in PEFR y1 
Arithmetic mean 
y2 
Deviation from 
mean(y1- y2 ) 
(y1-y2)2 
1 33.4 24.63 8.77 76.91 
2 20.34 24.63 -4.29 18.40 
3 27.8 24.63 3.17 10.04 
4 15.7 24.63 -8.93 79.74 
5 22.07 24.63 -2.56 6.55 
6 21.96 24.63 -2.67 7.13 
7 16.73 24.63 -7.9 62.41 
8 33.07 24.63 8.44 71.23 
9 34.4 24.63 9.77 95.45 
10 15.8 24.63 -8.83 77.97 
11 33.3 24.63 8.67 75.17 
12 31.53 24.63 6.9 47.61 
13 16.7 24.63 -7.93 62.88 
14 28.58 24.63 3.95 15.60 
15 17.2 24.63 -7.43 55.2 
16 33.4 24.63 8.77 76.91 
17 30.2 24.63 5.57 31.03 
18 17.2 24.63 -7.43 55.2 
19 16.7 24.63 -7.93 62.88 
20 17.2 24.63 -7.43 55.2 
21 33 24.63 8.37 70.06 
   
                                                                                                             (y1-y2)2  )                =     1113.57  
                                                                                                                   n2-1                              20  
STANDARD DEVIATION OF MEANVALUE IN GROUP 2                                    =   7.46 
 
 
STANDARD DEVIATION OF  MEAN VALUE OF GROUP 3. 
 
Sl.no % of improvement 
in PEFR z1 
Arithmetic mean z2 Deviation from 
mean(z1-z2) 
(z1-z2)2 
1. 0 7.29 -7.29 53.14 
2. 15.57 7.29 8.28 68.56 
3. 16.67 7.29 9.38 87.98 
4. 0 7.29 -7.29 53.14 
5. 0 7.29 -7.29 53.14 
6. 0 7.29 -7.29 53.14 
7. -10.76 7.29 18.05 325.8 
8. 0 7.29 -7.29 53.14 
9. 16.66 7.29 9.37 87.79 
10 0 7.29 -7.29 53.14 
11 15.23 7.29 7.94 63.04 
12 0 7.29 -7.29 53.14 
13 14.81 7.29 7.52 56.55 
14 34.36 7.29 27.07 732.78 
15 24.87 7.29 17.58 309.05 
16 13.37 7.29 6.08 36.96 
17 0 7.29 -7.29 53.14 
18 0 7.29 -7.29 53.14 
19 0 7.29 -7.29 53.14 
20  16.67                 7.29 9.38 87.98 
21 0 7.29 -7.29 53.14 
22 15 .91    7.29 8.62 74.3 
23 14.73 7.29 7.44 55.35 
24 -16.91 7.29 24.2 585.64 
25 13.34 7.29 6.05 36.6 
26 0 7.29 -7.29 53.14 
27 0 7.29 -7.29 53.14 
28 19.23 7.29 11.94 142.56 
29 0 7.29 -7.29 59.14 
30 14.93 7.29 7.64 58.36 
 
                                                                                                      (z1-z2)2  )                 =               3553.26 
                                                                                         n-1                                       30-1 
                                                                                                                   
                             
                                                                                                                                      =               122.53 
 
                                                                                                                                                                                                                       
           
            STANDARD DEVITION OF MEAN VALUE OF GROUP 3 = 11.07. 
   
 
 
 
                 Pooled standard deviation between group 1 & group 3 (SDP)  =           ( X1-X2 ) 2 +  (Z1-Z2)2 
                                                                                                                ( N1-1)           (n3-1) 
                                                                                                                           =16.44 
                      Applying Students  t’ Test; 
                    
                      t ‘ value for group 1&3     =         X  -  Z             =   46.55-7.29     =9.2 
                                                                   SDP      1  +  1                 16.44 x.26 
                                                                             N1     N 3 
                  
                      Degree of freedom   =( 26+30-2 ) =54  
                      P value for the degree of freedom 54 is < .001 and it is significant. 
                                                                
                
           Pooled standard deviation between group 2&3   (SDP) =    (Y1-Y2  )2 +  ( Z1-Z2)2 
                                                                                                              N2-1            N3-1 
                                                
                                                                                                            =13.4 
 
                  t ‘ value for group 2 &3 =       Y-Z                           = 24.63-7.29 
                                                              SD  P   1   +   1                    13.4 X.29 
                                                                         N 2       N 3                 = 4.62 
 
 
                      Degree of freedom  = (21+30-2)= 49. 
 
                      P value for the degree of freedom 49 is < .001 & it is significant. 
                                                                                         
 
 
 
     ASTHMA GRADING BEFORE TREATMENT 
 
 
 
 
 
 
 
 
ASTHMA GRADING AFTER TREATMENT 
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(48) 
DISCUSSION 
 
In the past,surgeons hesitated to perform surgical treatment for chronic 
rhinosinusitis in asthmatic patients because surgery for chronic rhinosinusitis with 
coexisting asthma was  thought to hinder the improvement of asthma symptoms further 
aggravate bronchial asthma.  Since the 1980’s , however,several authors have reported 
that medical or surgical treatment of  rhinosinusitis, although no causal relationship can 
be clearly determined,several findings and  evidence show  improvement in the clinical 
course of bronchial asthma in adult and pediatric  asthmatic patients with  chronic 
rhinosinusitis after medical or surgical treatment . 
 
Since the publication of Messerklinger’s classic work,which demonstrated an 
improved  understanding of the pathogenesis of rhinosinusitis, ESS has emerged as the 
surgical  procedure of choice for treating chronic rhinosinusitis that is refractory to 
medical management . A survey of the literature reveals a number of studies reporting on 
the effects  of ESS on the course of asthma in asthmatic patients with chronic 
rhinosinusitis. In this study asthma severity, frequency of attacks, and pulmonary 
function were all improved. 
 
 (49) 
In our study among 107 patients, 47 had sinusitis.After surgical management the average 
improvement in PEFR is 46.55 & after conservative management average improvement 
in PEFR is  24. 63 which when compared to the control group is significant. The follow  
up period  is for three months .  In our study we utilised both objective and  subjective 
parameters to assess the effect of management of rhinosinusitis in the clinical course of 
bronchial asthma. 
This study demonstrates that a combination of FESS, careful postoperative care, and 
appropriate medical therapy for chronic rhinosinusitis has a favorable  effect on asthma in 
patients with symptomatic chronic sinusitis.  
 
 
 
 
 (50) 
LITERATURE REVIEW 
 
 In the Department of Otorhinolaryngology Head and Neck Surgery, University of 
Pennsylvania Medical Center, Philadelphia, USA  using objective and subjective criteria, a 
study was performed by Senior & Kennedy(18)  to assess the long-term impact of 
functional endoscopic sinus surgery (FESS) in patients with chronic rhinosinusitis and 
asthma at an average follow-up of 6.5 years. One hundred and twenty patients who 
underwent FESS for chronic rhinosinusitis were followed. Seventy-two (60%) patients 
responded to a follow-up questionnaire, and 30 (42%) of them reported a history of 
asthma. Subjective levels of improvement and assessments of medication need were 
evaluated and statistically assessed with parametric and nonparametric methods. Of these 
30 patients, 27 (90%) reported that their asthma was better than it had been before FESS. 
Average reported improvement increased from 49% at 1.1 years after surgery to 65% at 6.5 
years after surgery. Asthma attacks declined in 20 of 27 (74.1%). Medication use for 
asthma showed similar improvement, with approximately half reporting less inhaler usage 
and nearly two thirds reporting less oral steroid use.  
 
 
 
(51) 
In  the Department of Surgery, University of Missouri-Columbia, by Cook & Nishioka(4). 
Twenty asthma patients who underwent functional endoscopic sinus surgery for chronic 
sinusitis were studied. Medical records and questionnaire data for these 20 patients were 
studied regarding the impact of sinus disease and functional endoscopic sinus surgery on 
their asthma .95% reported that their asthma was worsened by their sinus disease and 
85% reported that functional endoscopic sinus surgery improved their asthma .Of the 13 
patients who used both inhalers and systemic medication, 53.8% were able to eliminate 
some of their medication .Furthermore, 61.5% of these patients had a concomitant 
reduction in their inhaler use .All patients (six) who used only inhalers experienced a 
reduction in their inhaler use, and two patients were able to eliminate their inhalers 
completely. One of two patients who were steroid dependent was able to discontinue 
steroids after surgery. Of patients who used steroids intermittently (13), 53.8% were able 
to eliminate the use of steroids after surgery Patients who required preoperative hospital 
admissions (4) and emergency room or urgent physician office visits (18) had a 75.0% 
and 81.3% (p < 0.001) reduction in visits, respectively, after surgery. Because 43% of the 
cost of asthma is the result of hospitalizations and emergency department/urgent 
physician office visits, a significant impact on health care costs can be realized with 
functional endoscopic sinus surgery in this patient population. 
 
 
 
 
 
(52) 
A study was carried out at the Institute of Allergy and the Department of  otolaryngology 
of Shanxi Medical University. Patients with both CRS and asthma  were considered to be 
enrolled into this study. Thirty-eight patients with both  CRS and chronic asthma were 
enrolled to this study. A group of 25 patients with CRS alone were enrolled into this 
study served as controls. All patients required  surgical treatment since they had tried 
different medical remedies and had not  obtained satisfactory results. These 38 patients 
also suffered from perennial  asthma. All of them clearly stated treatment since they had 
tried different medical remedies and had not obtained satisfactory results.  Their 
symptoms could be  controlled by inhaling 2-adrenoreceptor agonists, or theophyline 
preparations. Lung function tests were performed for patients with asthma before and 2 
months after sinus surgery. A group of 23 patients with asthma alone were enrolled into  
this study . Clinical symptoms of patients with CRS-asthma and CRS alone were  
improved after FESS.Two months after the FESS, FEV1 value fall-percentage in  
response to antigen challenge was also improved in CRS-asthma patients  improvement 
>12% could be considered as positive results), but not in patients with asthma alone .The 
post-FESS clinical asthma scores decreased significantly  the clinical symptoms of CRS, 
such as nasal blockage and nasal purulent  secretions were also assessed by patients. The 
FESS resulted in markedly attenuating the CRS clinical scores clinical study of 
endoscopic sinus surgery for  sinusitis in patients with bronchial asthma served as asthma 
controls. Clinical  symptoms of patients with CRS-asthma and CRS alone were improved 
after  FESS. 
 
(53) 
Rachelefsky(1) et al were early observers of worsening  of lower airway disease with  
sinusitis. 48 children with asthma were identified to have chronic daytime and  night time 
symptoms of cough and wheeze. Water’s view of paranasal sinuses revealed 
abnormalities in all the 48 children (mucosal thickening, maxillary sinus  opacification 
(or) air fluid levels) all the children treated with antibiotics. At the  completion of 
treatment , nearly 80% had normal radiographs of paranasal sinuses. Of the tested, 67% 
had normal pulmonary functions. This study provides  some evidence  that sinusitis can 
affect lower airway disease.   
Studies of adult patients  by Slavin  & Slavin(2)  focused on corticosteroid dependent  
asthmatics with chronic rhinosinusitis not responding to medical management . 
Subsequent surgical intervention created significant improvement in chronic asthma in 
two thirds of the patient. 
Ramsdale(9) et al (1985) used methacholine and isocapnic hyperventilation to measure 
bronchial hyper responsiveness in 25 subjects with rhinitis who didn’t  have the diagnosis 
of bronchial asthma. In six subjects , the provocative  concentration of the methacholine 
that decreased the FEV1 by 20% was less than  8mg/ml in a range of responsiveness 
found in asthma. There were four additional  subjects whose Provocative concentration 
was in 8-16mg/ml range . The observation of ramsdale etal also indicate hyper 
responsiveness of lower airway  in subjects with rhinitis. 
 
(54) 
Bellofiore(9) et.al (1987) used sensitized  rats to assess the contribution of upper and  
lower airways to the changes in pulmonary resistance after inhalation of antigen. After 
inhalation of antigen through nose to the upper and lower airway resistance increased. 
When the antigen was given via nasal route both  upper and lower airway resistance 
increases. In contrast when the antigen was  introduced through tracheostomy lower 
airway resistance increased but not the  upper airway.  To explore the possible 
mechanism by which  upper airway allergic response enhanced lower airway  
function,the animals pretreated with  inhaled atropine. Atropine blocked the increase in 
lower airway resistance  following application of antigen these observation suggest that 
reaction of upper  & lower respiratory tract are mediated by cholinergic mechanisms.   
 
Brugman(22) and co-workers developed a rabbit model to identify mechanisms  
associated with lower airway changes in sinusitis. Rabbits have well  developed maxillary 
sinuses which are accessible  and lower airway physiology measured . Maxillary sinuses 
were then injected with the active complement component C5a to cause a inflammatory 
process. Following C5a injection rabbits developed bronchial responsiveness. Animals 
received C5a in knee bursa to determine whether an lower airway changes. Rabbits were 
intubated prior to C5a injection, injected but kept in the head down position (or) in 
upright position.Animals in upright position and not intubated noted to have bronchial 
hyperresponsiveness. These observation suggests that drainage of material to the  lower 
airway may contribute to changes in airway function. 
(55) 
Hun-Jong Dhong,Seoul, performed a study on the effect of endoscopic sinus surgery on 
asthmatic patients with chronic rhinosinusitis. They performed a study to evaluate the 
effectiveness of FESS in patients with asthma who underwent FESS for rhinosinusitis. 
The  use of antiasthma medication and postoperative asthma symptoms was analyzed. 
Objective changes  of pulmonary function tests were evaluated. There was a significant 
improvement in diurnal and nocturnal asthma symptoms. Improvements in asthma 
medication scores were also confirmed, and individual asthma symptoms(dyspnea, 
cough,wheezing, and sputum production) improved significantly. Despite a reduction in 
use of antiasthma medication after FESS,the parameters of the pulmonary function tests 
did not change. Both subjectively and objectively, it seems that FESS, when used to treat 
asthmatic patients with chronic rhinosinusitis, can play a significant role in the clinical 
improvement of asthma. 
 
 
 
 
 
 
 
 
(56) 
CONCLUSION 
 
 
• All  the  bronchial  asthma  patients  with nasal symptoms should be 
evaluated by Otorhinolaryngologist  for Rhinosinusitis screening & 
may be included in their management protocol. 
 
 
• Treating the rhinosinusitis improves the peak expiratory flow rate  in 
asthma patients. 
 
 
• Managing rhino sinusitis alleviates the asthma symptoms and improve  
their quality of life . 
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Screening proforma 
Name      age/sex  occupation 
Address 
Nasal block                    
Post nasal discharge 
 
Hyposmia/anosmia 
 
Facialpain / pressure 
 
Facial fullness / congestion 
 
Sneezing 
 
Bleeding per nose 
 
Change in voice 
 
Headache 
 
Halitosis 
 
Dental pain 
 
Cough 
 
Fatigue 
 
Ear pain/pressure 
 
Fever 
 
Duration of bronchial asthma 
 
Frequency of attacks, diurnal   nocturnal 
 
Preeipitating factors 
 
Medications 
 
Family h/o of asthma/allergy 
 
H/o Tuberculosis/cardiac disease/DM/HT/STD/ Previous nasal surgeries 
H/o Smoking / alcohol intake /snuff usage/betel nut chewing 
 
Examination of nose 
   External contour    columella 
   Septum 
              
 Right Left 
Floor of nasal cavity   
Inferior meatus   
Inferior turbinate   
Middle meatus   
Middle turbinate   
Post  nasal   
Coldspatula test   
Ear  
Throat/neck 
Respiratory system      CVS 
 
 DIAGNOSTIC NASAL ENDOSCOPY FORM 
 
GOVERNMENT STANLEY MEDICAL COLLEGE, CHENNAI. 
 
 
 Right Left 
Inferior meatus   
Inferior turbinate   
Agger nasi   
Uncinate   
Middle meatus   
Middle turbinate   
Spheno ethmoidal recess   
Turbinoseptal classification   
Mucosa   
Nasopharynx   
 
 
 
 
 
 
 
  
 
 
 
 MUCOCILIARY CLEARANCE IN SINUSES 
 
            
                                        
 
             
                                                                                                
         
          
                         
 
 
  
LATERAL WALL OF NOSE             
           
 
 
 
 
bulla                        middle turbinate       hiatus semilunaris    uncinate         aggernasi 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
CT SCAN PARANASAL SINUSES CORONAL SECTIONS 
SHOWING EVIDENCE OF SINUSITIS 
 
 
 
 
                                
 
 
 
 
 
                              
                                  
  
 
 
 
 
                         
 
 
 
 
 
 
 
                          
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
                                                                                             
                            
 
                                          bullous middle turbinate 
 
 
 
 
 
 
                             
 
                            wide middle meatal antrostomy 
